Michael Oklowich
Analyst
Maxim Group
Equibles does not estimate personal net worth.
About Michael Oklowich
Michael Oklowich is recorded as Analyst at Maxim Group. Michael Oklowich has spoken on 1 earnings call across 1 company, most recently for Rani Therapeutics Holdings, Inc. on March 26, 2026. The companies whose calls Michael Oklowich spoke on are classified in the Healthcare sector.
Michael Oklowich on recent calls
“I guess I'd like to follow up and talk a little bit more about the Phase I study for RT-114, and particularly the importance of that study and what new questions we should be looking for answers to, particularly in the context of PG-102 already having demonstrated some efficacy and safety for the active ingredient.”
Affiliation history
-
Maxim Group
Analyst
Transcript header (unverified)
Current